Grey Matters Health Opens First U.S. Brain-Dedicated PET Neuroimaging Clinic
Event summary
- Grey Matters Health to open its first NovaScan Neuroimaging Clinic in Davie, Florida by September 30, 2026.
- Clinic will use FDA-cleared CareMiBrain™ system for brain PET scans, reducing radiation exposure by 25%.
- Scans covered by Medicare, Medicaid, and private insurance for patients 65+ with neurodegenerative diseases.
- Grey Matters plans to expand the clinic network nationally.
The big picture
Grey Matters Health is entering a rapidly growing market for Alzheimer’s diagnostics, driven by FDA-approved treatments that require beta-amyloid detection. The current supply of PET scanners in the U.S. is insufficient to meet demand, creating an opportunity for specialized clinics like NovaScan Neuroimaging Clinics™. The company's focus on reducing radiation exposure and streamlining patient care could position it as a key player in neurodegenerative disease management.
What we're watching
- Market Expansion
- Whether Grey Matters can successfully scale its clinic network across the U.S. to meet growing demand for Alzheimer’s diagnostics.
- Regulatory Compliance
- How the FDA-cleared CareMiBrain™ system will perform in real-world settings and maintain compliance with evolving regulations.
- Competitive Dynamics
- The pace at which competitors like Eisai, Biogen, and Eli Lilly respond to Grey Matters' entry into the brain PET scan market.
Related topics
